DE69027112D1 - Impfstoffzusammensetzung - Google Patents

Impfstoffzusammensetzung

Info

Publication number
DE69027112D1
DE69027112D1 DE69027112T DE69027112T DE69027112D1 DE 69027112 D1 DE69027112 D1 DE 69027112D1 DE 69027112 T DE69027112 T DE 69027112T DE 69027112 T DE69027112 T DE 69027112T DE 69027112 D1 DE69027112 D1 DE 69027112D1
Authority
DE
Germany
Prior art keywords
vaccine composition
vaccine
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69027112T
Other languages
English (en)
Other versions
DE69027112T2 (de
Inventor
Alan Husband
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Auspharm International Ltd
Original Assignee
Auspharm International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auspharm International Ltd filed Critical Auspharm International Ltd
Publication of DE69027112D1 publication Critical patent/DE69027112D1/de
Application granted granted Critical
Publication of DE69027112T2 publication Critical patent/DE69027112T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69027112T 1989-01-23 1990-01-19 Impfstoffzusammensetzung Expired - Fee Related DE69027112T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ236889 1989-01-23
PCT/AU1990/000014 WO1990007935A1 (en) 1989-01-23 1990-01-19 Vaccine composition

Publications (2)

Publication Number Publication Date
DE69027112D1 true DE69027112D1 (de) 1996-06-27
DE69027112T2 DE69027112T2 (de) 1997-01-09

Family

ID=3773656

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69027112T Expired - Fee Related DE69027112T2 (de) 1989-01-23 1990-01-19 Impfstoffzusammensetzung

Country Status (8)

Country Link
EP (1) EP0454735B1 (de)
AU (1) AU638970B2 (de)
DE (1) DE69027112T2 (de)
DK (1) DK0454735T3 (de)
HK (1) HK1000113A1 (de)
NZ (1) NZ232190A (de)
WO (1) WO1990007935A1 (de)
ZA (1) ZA90474B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE154759T1 (de) * 1990-11-08 1997-07-15 Univ London Mycobacterium als adjuvans für antigene
CA2083553A1 (en) * 1991-11-25 1993-05-26 Kuniharu Seki Immunogen composition
AUPN178995A0 (en) * 1995-03-16 1995-04-13 University Of Melbourne, The Antigen composition
UA56132C2 (uk) * 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
DE69838992T2 (de) * 1997-09-05 2008-12-24 Glaxosmithkline Biologicals S.A., Rixensart Öl-in-Wasser Emulsionen mit Saponinen
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
CN104383526B (zh) 2005-12-29 2018-09-18 贝林格尔.英格海姆维特梅迪卡有限公司 Pcv2免疫原性组合物用于减轻猪临床症状的用途
PL1968630T3 (pl) 2005-12-29 2018-08-31 Boehringer Ingelheim Vetmedica, Inc. Multiwalentne immunogenne kompozycje PCV2
US20100129397A1 (en) 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
EP2094872B2 (de) 2006-12-15 2020-02-19 Boehringer Ingelheim Animal Health USA Inc. Behandlung von anti-PCV2 Antikörper seropositiver Schweine mit PCV2 antigen
EP1941903A1 (de) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxe und Behandlung von PRDC
EP1958644A1 (de) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Vorbeugung und Behandlung von subklinischer PCVD
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
EP2242511A4 (de) 2008-01-23 2012-10-24 Boehringer Ingelheim Vetmed Immunogene pcv2-zusammensetzungen gegen mycoplasma hyopneumoniae und verfahren zur herstellung solcher zusammensetzungen
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
JP6821429B2 (ja) 2013-09-25 2021-01-27 ゾエティス・サービシーズ・エルエルシー Ｐｃｖ２ｂ分岐ワクチン組成物及び使用方法
EA035265B1 (ru) 2013-10-02 2020-05-21 Бёрингер Ингельхайм Энимал Хелс Ю-Эс-Эй Инк. Вариант белка opc2 pcv2 и содержащие его вирусоподобные частицы

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5540568B2 (de) * 1972-10-05 1980-10-18
ZA738364B (en) * 1972-12-04 1974-09-25 Rit Rech Ind Therapeut Piglet colibacillosis vaccines and process for their preparation
FR2298337A1 (fr) * 1975-01-23 1976-08-20 Pasteur Institut Procede de conservation de vaccins contenant des mycobacteries vivantes
US4167560A (en) * 1977-04-12 1979-09-11 Texas Vet Lab, Inc. Polyvalent shipping fever vaccine
CA1188986A (en) * 1981-04-30 1985-06-18 Real Lallier Isolation of escherichia coli heat-stable enterotoxin of porcine origin
CA1338705C (en) * 1981-10-22 1996-11-12 Roy Curtiss Iii Vaccines obtained from antigenic gene products of recombinant genes
FR2565825B1 (fr) * 1984-06-15 1990-07-13 Centre Nat Rech Scient Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
US4806350A (en) * 1986-04-18 1989-02-21 Norden Laboratories, Inc. Vaccine formulation
EP0283840A3 (de) * 1987-03-26 1989-08-09 Ml Technology Ventures, L.P. Mycoplasma hyopneuminiae-Antigen und seine Vewendungen

Also Published As

Publication number Publication date
AU638970B2 (en) 1993-07-15
AU4959990A (en) 1990-08-13
HK1000113A1 (en) 1997-12-05
DK0454735T3 (da) 1996-10-07
WO1990007935A1 (en) 1990-07-26
EP0454735A4 (en) 1992-01-15
EP0454735B1 (de) 1996-05-22
DE69027112T2 (de) 1997-01-09
NZ232190A (en) 1991-10-25
EP0454735A1 (de) 1991-11-06
ZA90474B (en) 1990-10-31

Similar Documents

Publication Publication Date Title
DE69027112D1 (de) Impfstoffzusammensetzung
BR9007196A (pt) Composicao
SE9000221D0 (sv) Komposition
BR9006919A (pt) Composicao de rimel
DK0394026T3 (da) Formulering
KR900011476A (ko) 백신 제제
DK272889D0 (da) Vaccine
BR9006584A (pt) Composicao de poli-oxi-metileno
DK189788D0 (da) Vaccine
DE69027139D1 (de) Zusammensetzungen
DK0381427T3 (da) Vaccinesammensætning
FI920468A (fi) Medicinskt droppglas med kroppsviktsskala
BR9005424A (pt) Composicao
BR9007246A (pt) Preparacao de vacinas
ATA149789A (de) Schienenrad
KR910009229U (ko) 개량 흙손
SE8901727D0 (sv) Komposition
NO950342D0 (no) Oppsvellingsmiddel-sammensetning
IT9020332A0 (it) Composizione farmaceutica
SE8904063D0 (sv) Farmaceutisk komposition
LV10233A (lv) Stabila artropodikala kompozicija
MC2075A1 (fr) Over stop
SE9500143D0 (sv) Formelement
BR6900732U (pt) Reoviscosimetro
BR6901807U (pt) Fulao

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee